The effect of isosorbide dinitrate on uterine and ovarian blood flow during oestrous cycle and early pregnancy in maresby D. Zoller, J. Lüttgenau, H. Bollwein

Journal of Equine Veterinary Science

About

Year
2014
DOI
10.1016/j.jevs.2013.10.122
Subject
Equine

Similar

Problems the market can't solve

Authors:
The NGO Poverty and Affluence Worki
1992

Behavioural and ovarian changes during the oestrous cycle in the boran (Bos indicus)

Authors:
C.A. Llewelyn, C.D. Munro, A.G. Luckins, T. Jordt, M. Murray, E. Lorenzini
1987

Text

The effect of isosorbide dinitrate on uterine and ovarian blood flow during oestrous cycle and early pregnancy in mares

D. Zoller, J. Lüttgenau, H. Bollwein

Journal of Equine Veterinary Science 34 (2014) 167

Contents lists available at ScienceDirect

Journal of Equine Veterinary Science journal homepage: www.j -evs.comto 11 after insemination. The uterine and ovarian blood supplies were studied by Doppler ultrasonography of both uterine arteries and both ovarian arteries once a day cycling as well as in early pregnant mares. If the rise in genital perfusion has an effect on fertility has to be investigated in further studies.It has been proposed that in mares fertility could be affected by uterine blood flow [Blaich U,et.al,. Pferdeheilkunde 1999;15:547-50].An adequate blood supply is essential for hormonal signalling, uterine contractility, placentation and feto-endometrial interactions (Le Blanc

MM, Causey RC. Reprod Domest Anim 2009;44:11-22.The objective of this study was to investigate the effects of the exogenous application of the vasodilator nitric oxide donor isosorbide dinitrate (ISDN) on uterine and ovarianperfusion in cycling mares and early pregnant mares by using transrectal Doppler ultrasonography. Six Trotter mares, aged 7 to 14 years were examined daily during three oestrous cycles.

Four of these mares were additionally examined during early pregnancy. Mares were treated with placebo (lactose 60 mg), a low dose of ISDN (30 mg) and a high dose of ISDN (60 mg) orally (one treatment per cycle, in random order) every 12 h from Day 1 to 11 of the cycle (Day 0 ¼ day of ovulation following prostaglandin-induced luteolysis). Four of these mares were additionally treated with a placebo (lactose 60mg) or ISDN (60mg) orally every 12 h fromDay 10737-0806/$ – see front matter  2014 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jevs.2013.10.122immediately prior to oral treatment starting on Day 1. Blood flow resistance was determined semi-quantitatively using the pulsatility index (PI) and plasma progesterone concentrations were determined with an enzyme immunoassay.

Mean PI values of both uterine arteries and PI values of the dominant ovarian arterywere lower (P<0.05) and themean concentration of plasma progesterone higher (P<0.0001) after administration of ISDN30 aswell as ISDN60 compared to placebo cycles. No differences (P>0.05) occurred inmean

PI values of both uterine arteries between placebo pregnancies and ISDN 60 pregnancies, ISDN 30- and ISDN 60 cycles, but their mean PI values were lower (P<0.05) compared to placebo cycles. During ISDN 60 pregnancies only PI values in the dominant ovarian artery decreased (P<0.05) compared to placebo pregnancies. There was no difference betweenmean PI values of the dominant ovarian artery in the ISDN 60 pregnancies and the ISDN 60 cycles (P>0.05). Plasma progesterone concentrations were higher (P<0.05) during ISDN 60 pregnancies compared to placebo pregnancies. In conclusion, ISDN affects genital perfusion inClinic of Reproductive Medicine, Vetsuisse-Faculty University of Zurich